Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 40: 138-144, 1994;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weykamp, C. W.
Right arrow Articles by van der Slik, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weykamp, C. W.
Right arrow Articles by van der Slik, W.

Clinical Chemistry, Vol 40, 138-144, Copyright © 1994 by American Association for Clinical Chemistry

Effect of calibration on dispersion of glycohemoglobin values determined by 111 laboratories using 21 methods

CW Weykamp, TJ Penders, FA Muskiet and W van der Slik
Department of Clinical Chemistry, Queen Beatrix Hospital, Winterswijk, The Netherlands.

One hundred eleven laboratories, using 21 different methods based on five different principles, determined glycohemoglobin (GHb) percentages in two identical series of six lyophilized hemolysates and three similarly processed calibrators, distributed 3 months apart. To assign GHb percentages to calibrators, we used HbA1c results from nine participants who used the Bio-Rad Diamat high-performance liquid chromatographic method. Three-point calibration with assigned values improved mean intralaboratory variation (CV) from 6.6% to 3.5%. For samples with low (5.5%) and high (14.1%) GHb percentages, respectively, calibration decreased interlaboratory variation per method (from 10% to 4% and from 6% to 3%), inter-method variation (from 18% to 4% and from 16% to 3%), and overall interlaboratory variation (from 25% to 7% and from 15% to 4%). Without calibration, 71% of the laboratories did not meet the clinically desirable intralaboratory CV of 3.5%; calibration reduced this proportion to 39%. We conclude that, irrespective of the analytical method used, calibration greatly reduces all sources of GHb variation.


The following articles in journals at HighWire Press have cited this article:


Home page
 Lab MedHome page
R. R. Little and C. L. Rohlfing
HbA1c Standardization: Background, Progress and Current Issues
Lab Med, June 1, 2009; 40(6): 368 - 373.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, C. M. Peterson, and D. B. Sacks
Tests of Glycemia in Diabetes
Diabetes Care, July 1, 2004; 27(7): 1761 - 1773.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Hoelzel, C. Weykamp, J.-O. Jeppsson, K. Miedema, J. R. Barr, I. Goodall, T. Hoshino, W. G. John, U. Kobold, R. Little, et al.
IFCC Reference System for Measurement of Hemoglobin A1c in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison Study
Clin. Chem., January 1, 2004; 50(1): 166 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Clin. Chem., March 1, 2002; 48(3): 436 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. R. Little, C. L. Rohlfing, H.-M. Wiedmeyer, G. L. Myers, D. B. Sacks, and D. E. Goldstein
The National Glycohemoglobin Standardization Program: A Five-Year Progress Report
Clin. Chem., November 1, 2001; 47(11): 1985 - 1992.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. B. Roberts, A. B. Amara, M. Morris, and B. N. Green
Long-Term Evaluation of Electrospray Ionization Mass Spectrometric Analysis of Glycated Hemoglobin
Clin. Chem., February 1, 2001; 47(2): 316 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. P.F. Turner, B. Chen, and S. A. Piletsky
In Vitro Diagnostics in Diabetes: Meeting the Challenge
Clin. Chem., September 1, 1999; 45(9): 1596 - 1601.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J.-C. Rymer, R. Sabatier, A. Daver, J. Bourleaud, M. Assicot, J. Bremond, J. Rapin, S. L. Salhi, B. Thirion, A. Vassault, et al.
A New Approach for Clinical Biological Assay Comparison and Standardization: Application of Principal Component Analysis to a Multicenter Study of Twenty-One Carcinoembryonic Antigen Immunoassay Kits
Clin. Chem., June 1, 1999; 45(6): 869 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Gerlo and F. Gorus
Calibration of ion-exchange HPLC measurements of glycohemoglobin: effect on interassay precision
Clin. Chem., December 1, 1997; 43(12): 2353 - 2357.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
U. Kobold, J.-O. Jeppsson, T. Dulffer, A. Finke, W. Hoelzel, and K. Miedema
Candidate reference methods for hemoglobin A1c based on peptide mapping
Clin. Chem., October 1, 1997; 43(10): 1944 - 1951.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Halwachs-Baumann, S. Katzensteiner, W. Schnedl, P. Purstner, T. Pieber, and M. Wilders-Truschnig
Comparative evaluation of three assay systems for automated determination of hemoglobin A1c
Clin. Chem., March 1, 1997; 43(3): 511 - 517.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Association for Clinical Chemistry.